Fundz

Fundz Deep Dive

Everything you need to win Cyril Grandchamp-Desraux — in one platform.

Who to reach, what to say, and why now on Cyril Grandchamp-Desraux — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Cyril Grandchamp-Desraux — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Ferring Pharmaceuticals Appoints Pierre Yves Berclaz As Chief Medical Officer and Cyril Grandchamp Desraux As Chief Commercial Officer

PRIVATEApr 09, 2024•about 2 years ago

Position

Chief Commercial Officer

Company

Ferring Pharmaceuticals

Cyril Grandchamp-Desraux
Saint-PrexBiotechnologyHealth Care

Description

Ferring Pharmaceuticals announced the appointment of Pierre-Yves Berclaz as Chief Medical Officer in January 2023 and Cyril Grandchamp-Desraux as Chief Commercial Officer in January 2024, while Jean-Frédéric Paulsen took over as Chairman of the Board of Directors.

Company Information

Company

Ferring Pharmaceuticals

Location

Saint-Prex, Vaud, Switzerland

About

Ferring Pharmaceuticals is a privately owned, research-driven, specialty biopharmaceutical group committed to building families and helping people live better lives. We are leaders in reproductive medicine and maternal health, and in areas of gastroenterology and urology. We are at the forefront of innovation in microbiome-based therapeutics and uro-oncology intravesical gene therapy. Ferring was founded in 1950 and employs more than 7,000 people worldwide. The company is headquartered in Saint-Prex, Switzerland, and has operating subsidiaries in more than 50 countries which markets its medicines in over 100 countries.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Ferring Pharmaceuticals's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.